Fresenius Medical Care AG & Co. KGaA EBITDA for the year ending December 31, 2024: USD 3.32 B

Fresenius Medical Care AG & Co. KGaA EBITDA is USD 3.32 B for the year ending December 31, 2024, a 2.53% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Fresenius Medical Care AG & Co. KGaA EBITDA for the year ending December 31, 2023 was USD 3.24 B, a -6.01% change year over year.
  • Fresenius Medical Care AG & Co. KGaA EBITDA for the year ending December 31, 2022 was USD 3.45 B, a -11.43% change year over year.
  • Fresenius Medical Care AG & Co. KGaA EBITDA for the year ending December 31, 2021 was USD 3.89 B, a -16.96% change year over year.
  • Fresenius Medical Care AG & Co. KGaA EBITDA for the year ending December 31, 2020 was USD 4.68 B, a 10.36% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)